Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Long-Term Investments: 2010-2021

Historic Long-Term Investments for Lifecore Biomedical (LFCR) over the last 12 years, with May 2021 value amounting to $44.8 million.

  • Lifecore Biomedical's Long-Term Investments fell 21.32% to $44.8 million in Q2 2021 from the same period last year, while for May 2021 it was $44.8 million, marking a year-over-year decrease of 21.32%. This contributed to the annual value of $44.8 million for FY2021, which is 21.32% down from last year.
  • As of FY2021, Lifecore Biomedical's Long-Term Investments stood at $44.8 million, which was down 21.32% from $56.9 million recorded in FY2020.
  • Lifecore Biomedical's 5-year Long-Term Investments high stood at $66.5 million for FY2018, and its period low was $44.8 million during FY2021.
  • Moreover, its 3-year median value for Long-Term Investments was $56.9 million (2020), whereas its average is $54.3 million.
  • In the last 5 years, Lifecore Biomedical's Long-Term Investments increased by 4.56% in 2018 and then declined by 21.32% in 2021.
  • Over the past 5 years, Lifecore Biomedical's Long-Term Investments (Yearly) stood at $63.6 million in 2017, then rose by 4.56% to $66.5 million in 2018, then decreased by 8.12% to $61.1 million in 2019, then decreased by 6.87% to $56.9 million in 2020, then dropped by 21.32% to $44.8 million in 2021.